Equities

Lumos Diagnostics Holdings Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Lumos Diagnostics Holdings Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.26
  • Today's Change-0.015 / -5.45%
  • Shares traded2.88m
  • 1 Year change+828.57%
  • Beta1.9651
Data delayed at least 20 minutes, as of Feb 11 2026 05:10 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Lumos Diagnostics Holdings Limited is an Australia-based company specializes in point-of-care (POC) diagnostic test technology to help healthcare professionals diagnose and manage medical conditions. The Company offers customized assay development and manufacturing services for POC tests and digital reader platforms. It also directly develops, manufactures, and commercializes Lumos-branded POC tests that target infectious and inflammatory diseases. Its Products offering is based on developing and commercializing its own suite of POC diagnostic products which are primarily focused on the diagnosis and management of infectious diseases. These include FebriDx, a POC test for detecting and differentiating viral and bacterial respiratory infections, and ViraDx, a rapid point-of-care diagnostic product that simultaneously tests for acute respiratory infections caused by the COVID-19, influenza A, and influenza B viruses. It manages the full development program for POC assays.

  • Revenue in AUD (TTM)17.49m
  • Net income in AUD-10.13m
  • Incorporated2018
  • Employees--
  • Location
    Lumos Diagnostics Holdings Ltd100 Albert Rd, Level 4SOUTH MELBOURNE 3205AustraliaAUS
  • Phone+61 39087-1598
  • Websitehttps://lumosdiagnostics.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Austco Healthcare Ltd81.41m5.93m134.91m174.0022.492.5315.331.660.0160.0160.21970.14211.023.914.67--7.439.3510.8313.3352.0553.077.298.391.28--0.1233--39.9819.76-16.1518.8325.65--
Epiminder Ltd-100.00bn-100.00bn138.40m---------------------------------------------------93.22---99.64------
Somnomed Ltd111.52m-3.46m151.82m300.00--3.2466.291.36-0.0163-0.01630.52620.21471.486.537.25---4.58-9.15-6.76-13.4659.8660.62-3.10-6.891.25-0.60670.1475--21.6314.2471.77--12.72--
EMvision Medical Devices Ltd5.63m-9.81m167.29m----16.58--29.72-0.1148-0.11480.06590.10860.2847--694.01---49.59-47.15-58.91-58.42-----174.21-105.97---93.340.2758---51.3141.83-259.23------
Lumos Diagnostics Holdings Ltd17.49m-10.13m218.13m----23.71--12.47-0.0147-0.01470.02570.01160.52057.044.91---30.15-40.19-54.60-61.1662.9552.57-57.93-132.460.6816-10.690.5315--11.4017.1216.40---61.58--
Aroa Biosurgery Ltd77.16m-1.55m234.92m261.00--2.98139.653.04-0.0045-0.00450.22360.22850.84321.563.08---1.70-8.53-1.85-9.7585.0782.71-2.01-15.205.740.31420.0706--22.6327.5664.12--14.62--
Orthocell Ltd8.85m-8.57m271.31m----16.70--30.65-0.0375-0.03750.03970.05990.28622.319.20---27.70-28.14-34.17-33.4768.9871.87-96.78-167.824.78--0.0381--36.4161.65-19.30--45.43--
Saluda Medical Inc-100.00bn-100.00bn297.39m--------------------------------------------------36.13---52.62------
EchoIQ Ltd101.41k-13.26m310.55m----13.47--3,062.31-0.0226-0.02260.00020.03530.0064--0.6446---83.87-68.78-89.84-81.95-----13,078.12-3,892.98----0.00--127.89-31.65-145.19---16.56--
Data as of Feb 11 2026. Currency figures normalised to Lumos Diagnostics Holdings Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.